Your session is about to expire
← Back to Search
Corticosteroid
Sarcoidosis related Calcium Dysregulation for Sarcoidosis
Phase 2 & 3
Waitlist Available
Led By Marc A Judson, MD
Research Sponsored by Albany Medical College
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age greater than 18 years old.
Able to understand English to the point of comprehending the informed consent form.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
Study Summary
ACTHAR Gel has activity in sarcoidosis associated hypercalciuria and calcium dysregulation.
Eligible Conditions
- Sarcoidosis
- Hypercalcemia
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reduction of 24 hour urine calcium
Secondary outcome measures
Change in 1,25 di-hydroxy Vitamin D during 12 week ACTHAR GEL treatment
Change in Sarcoidosis Health Questionnaire during 12 week ACTHAR GEL treatment
Change in Short Form-36 during 12 week ACTHAR GEL treatment
+6 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Sarcoidosis related Calcium DysregulationExperimental Treatment1 Intervention
Subjects with Sarcoidosis associated calcium dysregulation will be administered 80 units of Acthar Gel (adrenocorticotropic hormone) twice a week for 12 weeks. Clinical visits will be scheduled for -30 days, day of 1st dose and 4,8,12 and 16 week after 1st dose to monitor the health of subjects.
Find a Location
Who is running the clinical trial?
Albany Medical CollegeLead Sponsor
91 Previous Clinical Trials
11,487 Total Patients Enrolled
3 Trials studying Sarcoidosis
410 Patients Enrolled for Sarcoidosis
Marc A Judson, MDPrincipal InvestigatorAlbany Medical College
3 Previous Clinical Trials
46 Total Patients Enrolled
3 Trials studying Sarcoidosis
46 Patients Enrolled for Sarcoidosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger